SCHEMBL17367160

SCHEMBL17367160

c1ccc(-n2c3ccccc3c3c4ccc5c6c7ccccc7c7ccccc7c6n(-c6ccccc6)c5c4sc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ATM Q13315 2/20 0.42
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 4/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 4/20 0.31
MAPK8 P45983 2/20 0.31
IL1R1 P14778 1/20 0.31
KDR P35968 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
MEN1 O00255 3/20 0.31
MAPK9 P45984 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367129 0.88 L3MBTL1 (0.52) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL17367103 0.87 KDM4E (0.43) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL17367159 0.85 L3MBTL1 (0.41) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL17367163 0.84 KDM4E (0.40) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL17367117 0.83 L3MBTL1 (0.41) KDM4EL3MBTL1ATMHSD17B10ALDH1A1
SCHEMBL17366881 0.82 ALDH1A1 (0.39) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL19383003 0.81 KDM4E (0.53) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL19382733 0.81 KDM4E (0.57) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL17367156 0.80 ATM (0.39) KDM4EL3MBTL1ATMMAPK1HSD17B10
SCHEMBL15126986 0.80 GPR3 (0.37) KDM4EL3MBTL1ATMMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-08-18 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150380663-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CYP1A1, CRY1, CYP1B1 KDM4E 3404/4885L3MBTL1 717/4885ATM 3202/4885
US-10749118-B2 Heterocyclic compound and organic light-emitting device including the same CYP1A1, CRY1, CYP1B1 KDM4E 3404/4885L3MBTL1 717/4885ATM 3202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.